26 web-programmer-developer-"https:" "UCL" Postdoctoral positions at University of Colorado
Sort by
Refine Your Search
-
on this position will be the development and implementation of novel statistical and computational methods with applications to system biology problems and spatial transcriptomics datasets. The work will involve
-
Anschutz Medical Campus. The appointment will be for a two to three-year period. The Shellman Lab values innovation, collaboration, and mentorship, and is committed to supporting the professional development
-
conduct research focused on biochemical, cellular, and molecular mechanisms underlying human placental angiogenesis and development, with a primary focus on severe, early-onset fetal growth restriction
-
training (e.g., NIH TIDIRH program, university training or certificate program) and a degree in a health science or related field. The incumbent may receive additional training through the CU Dissemination
-
microRNA signaling in fetal growth restriction, and (2) pioneering in utero gene editing approaches to correct genetic disease before birth. Current projects include the development of CRISPR-Cas9–based base
-
, with a strong emphasis on deployment in real-world clinical environments. We study how clinicians interact with technology and develop tools that are practical, intuitive, and aligned with clinical needs
-
is to provide the highest level of medical care to patients, to train the next generation of academic leaders, and to expand on cutting-edge basic, translational, and clinical investigation in
-
will be afforded both time and resources to promote collaborative studies and develop new techniques. Key Responsibilities: • The post-doctoral fellow will plan, perform, analyze and oversee bench
-
record-keeping. Key Responsibilities: · Research (90%) o Designing and performing experiments in a methodical, scientific manner using advanced biomedical research techniques o Developing and
-
microRNA signaling in fetal growth restriction, and (2) pioneering in utero gene editing approaches to correct genetic disease before birth. Current projects include the development of CRISPR-Cas9–based base